Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)

Study Identifier
M13-765
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact

Study Details

Medical Condition
  • Schizophrenia
  • Study Drug
  • ABT-126
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    20 - 66 Years

    Protocol Summary

    This is a study of ABT-126 in the treatment of cognitive impairment associated with schizophrenia (CIAS), a long-term extension study to study M10-855 (NCT01655680).

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 95398
    Chino, California, United States, 91710
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 95381
    Costa Mesa, California, United States, 92626
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 95400
    Escondido, California, United States, 92025
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 95406
    Garden Grove, California, United States, 92845
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 95378
    National City, California, United States, 91950
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 95390
    Norwalk, California, United States, 90650
    Status
    Not applicable
    Showing {first} - {last} of {total} Results